Home > Research > Publications & Outputs > The tactile circumferential discriminator: a ne...

Research

View graph of relations

The tactile circumferential discriminator: a new, simple screening device to identify diabetic patients at risk of foot ulceration.

Research output: Contribution to Journal/Magazine › Journal article › peer-review

Published

Standard

The tactile circumferential discriminator: a new, simple screening device to identify diabetic patients at risk of foot ulceration. / Vileikyte, L.; Hutchings, G.; Hollis, S. et al.
In: Diabetes Care, Vol. 20, No. 4, 1997, p. 623-626.

Research output: Contribution to Journal/Magazine › Journal article › peer-review

Harvard

Vileikyte, L, Hutchings, G, Hollis, S & Boulton, AJM 1997, 'The tactile circumferential discriminator: a new, simple screening device to identify diabetic patients at risk of foot ulceration.', Diabetes Care, vol. 20, no. 4, pp. 623-626.

APA

Vileikyte, L., Hutchings, G., Hollis, S., & Boulton, A. J. M. (1997). The tactile circumferential discriminator: a new, simple screening device to identify diabetic patients at risk of foot ulceration. Diabetes Care, 20(4), 623-626.

Vancouver

Vileikyte L, Hutchings G, Hollis S, Boulton AJM. The tactile circumferential discriminator: a new, simple screening device to identify diabetic patients at risk of foot ulceration. Diabetes Care. 1997;20(4):623-626.

Author

Vileikyte, L. ; Hutchings, G. ; Hollis, S. et al. / The tactile circumferential discriminator: a new, simple screening device to identify diabetic patients at risk of foot ulceration. In: Diabetes Care. 1997 ; Vol. 20, No. 4. pp. 623-626.

Bibtex

@article{d24c5119940a4e5f9c19e9d5094c7145,
title = "The tactile circumferential discriminator: a new, simple screening device to identify diabetic patients at risk of foot ulceration.",
abstract = "OBJECTIVE: To evaluate the tactile circumferential discriminator (TCD) (Tacticon Medical Enterprises, West Chester, PA), a new, simple, handheld quantitative sensory testing device, in the identification of patients at potential risk of neuropathic ulceration. RESEARCH DESIGN AND METHODS: Patients with diabetes (n = 133) attending the Manchester Diabetes Centre or diabetic foot clinic seen within a 5-week period were assessed using the TCD, monofilaments, and vibration perception threshold (VPT) measured over the hallux. The sensitivity and specificity of each method in the identification of {"}high-risk{"} patients were compared. RESULTS: The TCD was easy to use, and there was a highly significant correlation between the results obtained compared with both filaments and VPT (P < 0.0001). Similarly, in the identification of patients at risk of ulceration, the TCD agreed with VPT in 75.2% of cases and with the monofilaments in 78.9%. In the identification of the 37 foot ulcer patients, TCD was highly sensitive (100%) but less specific (58.3%) than VPT (86.5%; 79.2%) and the monofilaments (91.9%; 76.0%). CONCLUSIONS: These data suggest that the TCD is a simple and reliable new technique for population screening for neuropathy and foot ulcer risk.",
author = "L. Vileikyte and G. Hutchings and S. Hollis and Boulton, {A. J. M.}",
year = "1997",
language = "English",
volume = "20",
pages = "623--626",
journal = "Diabetes Care",
issn = "1935-5548",
publisher = "American Diabetes Association Inc.",
number = "4",

}

RIS

TY - JOUR

T1 - The tactile circumferential discriminator: a new, simple screening device to identify diabetic patients at risk of foot ulceration.

AU - Vileikyte, L.

AU - Hutchings, G.

AU - Hollis, S.

AU - Boulton, A. J. M.

PY - 1997

Y1 - 1997

N2 - OBJECTIVE: To evaluate the tactile circumferential discriminator (TCD) (Tacticon Medical Enterprises, West Chester, PA), a new, simple, handheld quantitative sensory testing device, in the identification of patients at potential risk of neuropathic ulceration. RESEARCH DESIGN AND METHODS: Patients with diabetes (n = 133) attending the Manchester Diabetes Centre or diabetic foot clinic seen within a 5-week period were assessed using the TCD, monofilaments, and vibration perception threshold (VPT) measured over the hallux. The sensitivity and specificity of each method in the identification of "high-risk" patients were compared. RESULTS: The TCD was easy to use, and there was a highly significant correlation between the results obtained compared with both filaments and VPT (P < 0.0001). Similarly, in the identification of patients at risk of ulceration, the TCD agreed with VPT in 75.2% of cases and with the monofilaments in 78.9%. In the identification of the 37 foot ulcer patients, TCD was highly sensitive (100%) but less specific (58.3%) than VPT (86.5%; 79.2%) and the monofilaments (91.9%; 76.0%). CONCLUSIONS: These data suggest that the TCD is a simple and reliable new technique for population screening for neuropathy and foot ulcer risk.

AB - OBJECTIVE: To evaluate the tactile circumferential discriminator (TCD) (Tacticon Medical Enterprises, West Chester, PA), a new, simple, handheld quantitative sensory testing device, in the identification of patients at potential risk of neuropathic ulceration. RESEARCH DESIGN AND METHODS: Patients with diabetes (n = 133) attending the Manchester Diabetes Centre or diabetic foot clinic seen within a 5-week period were assessed using the TCD, monofilaments, and vibration perception threshold (VPT) measured over the hallux. The sensitivity and specificity of each method in the identification of "high-risk" patients were compared. RESULTS: The TCD was easy to use, and there was a highly significant correlation between the results obtained compared with both filaments and VPT (P < 0.0001). Similarly, in the identification of patients at risk of ulceration, the TCD agreed with VPT in 75.2% of cases and with the monofilaments in 78.9%. In the identification of the 37 foot ulcer patients, TCD was highly sensitive (100%) but less specific (58.3%) than VPT (86.5%; 79.2%) and the monofilaments (91.9%; 76.0%). CONCLUSIONS: These data suggest that the TCD is a simple and reliable new technique for population screening for neuropathy and foot ulcer risk.

M3 - Journal article

VL - 20

SP - 623

EP - 626

JO - Diabetes Care

JF - Diabetes Care

SN - 1935-5548

IS - 4

ER -